Melanoma bone metastasis-induced osteocyte ferroptosis via the HIF1α-HMOX1 axis

Abstract

Osteocytes are the main cells in mineralized bone tissue. Elevated osteocyte apoptosis has been observed in lytic bone lesions of patients with multiple myeloma. However, their precise contribution to bone metastasis remains unclear. Here, we investigated the pathogenic mechanisms driving melanoma-induced osteocyte death. Both in vivo models and in vitro assays were combined with untargeted RNA sequencing approaches to explore the pathways governing melanoma-induced osteocyte death. We could show that ferroptosis is the primary mechanism behind osteocyte death in the context of melanoma bone metastasis. HMOX1 was identified as a crucial regulatory factor in this process, directly involved in inducing ferroptosis and affecting osteocyte viability. We uncover a non-canonical pathway that involves excessive autophagy-mediated ferritin degradation, highlighting the complex relationship between autophagy and ferroptosis in melanoma-induced osteocyte death. In addition, HIF1α pathway was shown as an upstream regulator, providing a potential target for modulating HMOX1 expression and influencing autophagy-dependent ferroptosis. In conclusion, our study provides insight into the pathogenic mechanisms of osteocyte death induced by melanoma bone metastasis, with a specific focus on ferroptosis and its regulation. This would enhance our comprehension of melanoma-induced osteocyte death.

References

[1] Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lancet, 2023, 402: 485-502

[2] Sung H, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca. Cancer J. Clin., 2021, 71: 209-249

[3] Bedrosian I, et al.. Incidence of sentinel node metastasis in patients with thin primary melanoma (# 1 mm) with vertical growth phase. Ann. Surg. Oncol., 2000, 7: 262-267

[4] Zekri J, et al.. Complications of bone metastases from malignant melanoma. J. Bone Oncol., 2017, 8: 13-17

[5] Akslen LA, Hove LM, Hartveit F. Metastatic distribution in malignant melanoma. A 30-year autopsy study. Invasion Metastasis, 1987, 7: 253-263

[6] Caldaria A, et al.. Diagnosis and treatment of melanoma bone metastasis: a multidisciplinary approach. Dermatol. Ther., 2020, 33 e14193

[7] Matsugaki A, et al.. Impaired alignment of bone matrix microstructure associated with disorganized osteoblast arrangement in malignant melanoma metastasis. Biomolecules, 2021, 11: 131

[8] Alliston T. Biological regulation of bone quality. Curr. Osteoporos. Rep., 2014, 12: 366-375

[9] Seeman E. Bone quality: the material and structural basis of bone strength. J. Bone Miner. Metab., 2008, 26: 1-8

[10] Kitaura H, et al.. Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int. J. Mol. Sci., 2020, 21: 5169

[11] Bellido T. Osteocyte-driven bone remodeling. Calcif. Tissue Int., 2014, 94: 25-34

[12] Jilka RL, O’Brien CA. The role of osteocytes in age-related bone loss. Curr. Osteoporos. Rep., 2016, 14: 16-25

[13] Mazur CM, et al.. Osteocyte dysfunction promotes osteoarthritis through MMP13-dependent suppression of subchondral bone homeostasis. Bone Res., 2019, 7: 34

[14] Giuliani N, et al.. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation. Leukemia, 2012, 26: 1391-1401

[15] Sekita A, Matsugaki A, Ishimoto T, Nakano T. Synchronous disruption of anisotropic arrangement of the osteocyte network and collagen/apatite in melanoma bone metastasis. J. Struct. Biol., 2017, 197: 260-270

[16] Yao X, et al.. Chondrocyte ferroptosis contribute to the progression of osteoarthritis. J. Orthop. Transl., 2021, 27: 33-43

[17] Cao JY, Dixon SJ. Mechanisms of ferroptosis. Cell. Mol. Life Sci., 2016, 73: 2195-2209

[18] Tang D, Kroemer G. Ferroptosis. Curr. Biol., 2020, 30: R1292-R1297

[19] Imai, H., Matsuoka, M., Kumagai, T., Sakamoto, T. & Koumura, T. Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Apoptotic Non-apoptotic Cell Death 403, 143–170 (2017).

[20] Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics, 2019, 19: 1800311

[21] Yang Y, et al.. Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis. Bone Res., 2022, 10: 26

[22] Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res., 1988, 48: 6876-6881

[23] Yang M, et al.. Genetically fluorescent melanoma bone and organ metastasis models. Clin. Cancer Res., 1999, 5: 3549-3559

[24] Chiang S-K, Chen S-E, Chang L-C. A dual role of heme oxygenase-1 in cancer cells. Int. J. Mol. Sci., 2018, 20: 39

[25] Zhou, B. et al. Ferroptosis is a type of autophagy-dependent cell death. Semin. Cancer Biol. 66, 89–100 (2020).

[26] Liu J, et al.. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem. Biol., 2020, 27: 420-435

[27] Hou W, et al.. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy, 2016, 12: 1425-1428

[28] Yim WW-Y, Mizushima N. Lysosome biology in autophagy. Cell Discov., 2020, 6: 6

[29] Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell, 2004, 15: 1101-1111

[30] Jia Y, et al.. Osteocytes support bone metastasis of melanoma cells by CXCL5. Cancer Lett., 2024, 590: 216866

[31] Su K, Li Z, Yu Y, Zhang X. The prolyl hydroxylase inhibitor roxadustat: paradigm in drug discovery and prospects for clinical application beyond anemia. Drug Discov. Today, 2020, 25: 1262-1269

[32] Pin F, et al.. Non-bone metastatic cancers promote osteocyte-induced bone destruction. Cancer Lett., 2021, 520: 80-90

[33] Maroni P, Bendinelli P. Bone, a secondary growth site of breast and prostate carcinomas: role of osteocytes. Cancers, 2020, 12: 1812

[34] Jiang, Z. et al. Ferroptosis in osteocytes as a target for protection against postmenopausal osteoporosis. Adv. Sci. 11, 2307388 (2024).

[35] Lin H, et al.. EF24 induces ferroptosis in osteosarcoma cells through HMOX1. Biomed. Pharmacother., 2021, 136: 111202

[36] Meng Z, et al.. HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis. Life Sci., 2021, 284: 119935

[37] Fang X, et al.. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl. Acad. Sci. USA, 2019, 116: 2672-2680

[38] Anselmino N, et al.. Heme oxygenase-1 is a pivotal modulator of bone turnover and remodeling: molecular implications for prostate cancer bone metastasis. Antioxid. Redox Signal., 2020, 32: 1243-1258

[39] Guo YF, et al.. The role of autophagy in bone homeostasis. J. Cell. Physiol., 2021, 236: 4152-4173

[40] Gould, N. Lysosomal Degradation Regulates Sclerostin Protein Abundance in Response to Mechanical Stress and Parathyroid Hormone Treatment in Osteocytes (University of Maryland, 2021).

[41] Gould NR, et al.. Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein. eLife, 2021, 10 e64393

[42] Eskelinen E-L, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta (BBA)-Mol. Cell Res., 2009, 1793: 664-673

[43] Zhang Y, et al.. Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. Antioxid. Redox Signal., 2010, 13: 999-1009

[44] Mahapatra, K. K. et al. The lysosome as an imperative regulator of autophagy and cell death. Cell Mol. Life Sci. 1–15 (2021).

[45] Gao M, et al.. Ferroptosis is an autophagic cell death process. Cell Res., 2016, 26: 1021-1032

[46] Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis., 2019, 10 822

[47] Krishan S, et al.. Iron metabolism and autophagy: a poorly explored relationship that has important consequences for health and disease. Nagoya J. Med. Sci., 2015, 77: 1

[48] Su X, et al.. HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell Death Dis., 2022, 13 861

[49] Yang M, et al.. Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci. Adv., 2019, 5 eaaw2238

[50] Dong H, et al.. Ferroptosis related genes participate in the pathogenesis of spinal cord injury via HIF-1 signaling pathway. Brain Res. Bull., 2023, 192: 192-202

[51] Song X, et al.. HIF-1α induces hypoxic apoptosis of MLO-Y4 osteocytes via JNK/caspase-3 pathway and the apoptotic-osteocyte-mediated osteoclastogenesis in vitro. Tissue Cell, 2020, 67 101402

[52] Loots GG, et al.. Vhl deficiency in osteocytes produces high bone mass and hematopoietic defects. Bone, 2018, 116: 307-314

[53] Hulley PA, et al.. Hypoxia‐inducible factor 1‐alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl‐4‐hydroxylase 2. J. Pathol., 2017, 242: 322-333

[54] Shao J, et al.. A dual role of HIF1α in regulating osteogenesis–angiogenesis coupling. Stem Cell Res. Ther., 2022, 13: 59

[55] Noonan ML, et al.. Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23. Bone Res., 2023, 11: 7

[56] Xu K, et al.. Overexpression of HIF‐1α enhances the protective effect of mitophagy on steroid‐induced osteocytes apoptosis. Environ. Toxicol., 2021, 36: 2123-2137

[57] Shi J, et al.. Histone acetyltransferase P300 deficiency promotes ferroptosis of vascular smooth muscle cells by activating the HIF-1α/HMOX1 axis. Mol. Med., 2023, 29: 91

[58] Wu Y, et al.. Di-(2-ethylhexyl) phthalate exposure leads to ferroptosis via the HIF-1α/HO-1 signaling pathway in mouse testes. J. Hazard. Mater., 2022, 426: 127807

[59] Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF. Establishment of an osteocyte‐like cell line, MLO‐Y4. J. Bone Miner. Res., 1997, 12: 2014-2023

[60] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 2014, 15: 1-21

[61] Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J. Integr. Biol., 2012, 16: 284-287

[62] Reimand J, et al.. Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, Cytoscape and EnrichmentMap. Nat. Protoc., 2019, 14: 482-517

[63] Wickham, H., Chang, W. & Wickham, M. H. ggplot2: Create Elegant Data Visualisations Using the Grammar of Graphics. Version 2, 1–189 (2016).

[64] Gu Z. Complex heatmap visualization. Imeta, 2022, 1 e43

[65] Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 2002, 30: 207-210

[66] Kyrylkova, K., Kyryachenko, S., Leid, M. & Kioussi, C. Detection of apoptosis by TUNEL assay. Odontogenesis Methods Protoc. 887, 41–47 (2012).

[67] Van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM. Annexin V‐affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry J. Int. Soc. Anal. Cytol., 1998, 31: 1-9

[68] Martinez, A. M., Kim, A. & Yang, W. S. Detection of Ferroptosis by BODIPY™ 581/591 C11. Immune Med. Cancer Methods Protocols 2108, 125–130 (2020).

[69] Li H, et al.. Ferroptosis accompanied by• OH generation and cytoplasmic viscosity increase revealed via dual-functional fluorescence probe. J. Am. Chem. Soc., 2019, 141: 18301-18307

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation)(FOR 2886 (TP02))

EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013))(Consolidator Grant LS4-ODE)

RIGHTS & PERMISSIONS

The Author(s)